Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patent Reform Speeds Drug Development, At Least At The Signing Ceremony

This article was originally published in The Pink Sheet Daily

Executive Summary

President Obama announce seven initiatives to help move ideas from the lab to market as he signs the Leahy-Smith America Invents Act.
Advertisement

Related Content

We’re #8! PTO Ranks The Economic Power Of Pharma’s Patents
Patent Owners Struck With “Sticker Shock” At PTO’s Proposed Fees
White House Credits Eli Lilly With Help In Final Deal On Patent Reform Bill
White House Credits Eli Lilly With Help In Final Deal On Patent Reform Bill
BIO's "Big Ideas" Include Expanding FDA's Mission, Allowing "Progressive Approval"
NIH Drafting NCATS Budget Plan For Congress

Topics

Advertisement
UsernamePublicRestriction

Register

PS072781

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel